LifeStance Health Group (NASDAQ:LFST) Hits New 52-Week Low - Time to Sell?

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report)'s share price reached a new 52-week low during trading on Monday . The stock traded as low as $4.42 and last traded at $4.49, with a volume of 145403 shares trading hands. The stock had previously closed at $4.51.

Analyst Ratings Changes

Several brokerages recently issued reports on LFST. UBS Group raised LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 target price for the company in a research report on Tuesday, May 27th. Canaccord Genuity Group started coverage on LifeStance Health Group in a research note on Thursday, April 3rd. They set a "buy" rating and a $8.00 price target for the company. Finally, KeyCorp initiated coverage on LifeStance Health Group in a research note on Tuesday, April 8th. They set an "overweight" rating and a $9.00 price target for the company. One investment analyst has rated the stock with a sell rating, four have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $8.50.

LifeStance Health Group Stock Performance

The business's fifty day simple moving average is $5.41 and its 200-day simple moving average is $6.65. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.47 and a current ratio of 1.47. The company has a market capitalization of $1.72 billion, a P/E ratio of -44.15 and a beta of 1.16.

Insider Buying and Selling

In related news, insider Ujjwal Ramtekkar sold 16,000 shares of the business's stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $5.94, for a total transaction of $95,040.00. Following the transaction, the insider directly owned 113,435 shares in the company, valued at approximately $673,803.90. The trade was a 12.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 3.20% of the company's stock.

Hedge Funds Weigh In On LifeStance Health Group

Several institutional investors have recently added to or reduced their stakes in LFST. Choreo LLC boosted its holdings in LifeStance Health Group by 6.4% in the first quarter. Choreo LLC now owns 27,420 shares of the company's stock valued at $183,000 after acquiring an additional 1,661 shares during the last quarter. LPL Financial LLC increased its holdings in LifeStance Health Group by 6.0% in the fourth quarter. LPL Financial LLC now owns 37,584 shares of the company's stock valued at $277,000 after buying an additional 2,127 shares during the last quarter. Invesco Ltd. increased its holdings in LifeStance Health Group by 1.4% in the first quarter. Invesco Ltd. now owns 164,384 shares of the company's stock valued at $1,095,000 after buying an additional 2,238 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of LifeStance Health Group by 2.4% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 138,781 shares of the company's stock valued at $1,023,000 after purchasing an additional 3,305 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new position in shares of LifeStance Health Group during the first quarter valued at approximately $31,000. Institutional investors and hedge funds own 85.50% of the company's stock.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.